EN PL
  1. www.sciencepharma.com
  2. News
  3. Regulatory and procedural guidance
  4. EMEA: QRD recommendations on the expression of strength in the name of centrally authorised human medicinal products.

EMEA: QRD recommendations on the expression of strength in the name of centrally authorised human medicinal products.

22.01.2010
Directive 2001/83/EC requires a medicinal product labeled as invented name – strength-pharmaceutical form. The strength in the name of the product is the quantity of the active substance which is relevant for the correct identification and use the product.
The source of the news: http://www.ema.europa.eu/htms/human/qrd/docs/70722909en.pdf